LabCompass

Narasimha M. Beeraka

Medicine · Indiana University

Publications

148

Citations

4,694

Est. group size

Recurring co-author estimate

Active years

13

Publishing since 2014

Research summary
AI-generated

Narasimha M. Beeraka works in biomedical research focused on cancer biology and drug discovery, designing and testing new chemical compounds (such as pyrimidine and oxadiazole derivatives) that target signaling pathways in breast cancer and other cancers. The work also spans reviews of disease mechanisms in neurological disorders, metabolic and liver disease, and global disease burden studies. Much of the research combines synthetic chemistry, computational (in silico) screening, and laboratory (in vitro) cell studies.

Anticancer drug design and synthesisBreast cancer molecular targeting (EGFR, PI3K/Akt, apoptosis)Neurological and neurodegenerative disease mechanismsGlobal disease burden and epidemiology reviewsMedicinal chemistry and molecular modeling

Publication activity grew rapidly from 2019, peaked around 2022, and has remained high and fairly steady since (roughly 20+ papers per year).

Generated by claude-opus-4-8 from public bibliographic data · Jul 11, 2026

Publication cadence
Publications per year over the last 10 years — averaging 20.8/year recently
17182019: 2 publications192020: 12 publications202021: 21 publications212022: 29 publications29222023: 25 publications232024: 22 publications242025: 23 publications252026: 5 publications26
Recent publications
Publishes in
  • Current Medicinal Chemistry×14
  • Current Pharmaceutical Design×9
  • International Journal of Molecular Sciences×5
  • Research Square×5
  • Molecular Neurobiology×4

This profile was generated automatically from public scholarly data (OpenAlex). Group size and activity levels are estimates derived from co-authorship patterns.

Last updated Jul 11, 2026.

Claim or correct this profile